• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

MMA Payout

The Business of Combat Sports

  • Home
  • MMA
    • UFC
    • Bellator
    • One
    • PFL
  • Boxing
  • Legal
  • Ratings
  • Payouts
  • Attendance
  • Gate

Compounding pharmacies cause of 3 UFC fighters’ failed USADA tests

April 23, 2018 by Jason Cruz Leave a Comment

Junior dos Santos, Antonio Rogerio Nogueira and Marcos Rogerio de Lima have accepted six-month USADA suspensions after their supplements were traced back to compounding pharmacies that allegedly sold tainted supplements.

Compounding pharmacies prepare their medications onsite according to specifications contained in a written prescription instead of receiving their drug inventories like retail pharmacies and drugstores.

Via USADA release:

Despite their claims, the compounding pharmacies, located in Rio de Janeiro and Sao Paulo, Brazil, sold contaminated supplements to Junior dos Santos Almeida and Antonio Rogerio Nogueira, who each tested positive for hydrochlorothiazide, and Marcos Rogerio de Lima, who tested positive for hydrochlorothiazide and anastrozole. These substances are prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.

After testing supplements the athletes provided to USADA, the WADA-accredited laboratory in Salt Lake City confirmed the presence of multiple prohibited substances in the products. Through an ongoing investigation, USADA independently sourced supplements from the compounding pharmacies, which the Salt Lake City laboratory confirmed were also contaminated with hydrochlorothiazide, anastrozole, and several additional prohibited substances. Autoridade Brasileira de Controle de Dopagem (the Brazilian national anti-doping agency) and law enforcement agencies in Brazil assisted USADA’s investigation.

“We appreciate the cooperation of the athletes and international authorities in getting to the bottom of this situation, as it will hopefully prevent these problems from occurring in the future,” said Travis T. Tygart, CEO of USADA. “It’s unacceptable that these compounding pharmacies produced contaminated supplements for the public. And it’s another unfortunate example of why athletes must use extreme caution if using nutritional supplements. All too often, supplement products contain undeclared substances, including prohibited drugs, that can be dangerous to an athlete’s health. We are doing all we can to ensure that these types of suppliers are held accountable for introducing dangerous products like these into the marketplace.”

The contaminated products rule set forth in the UFC Anti-Doping Policy and the WADA Code provide the opportunity for a reduction in the otherwise applicable period of ineligibility if it is established that the positive test resulted from the use of a contaminated product.

“The rule recognizes that supplements can be a risk and also guards against unfounded and unfair reductions by requiring a thorough investigation of all claims of ‘contamination.’ The rule also ensures that athletes are not overly penalized when they have been diligent in what they use, and when it is proven the source of the positive is from a contaminated product, like in these cases,” Tygart said.

Following USADA’s investigation, Almeida, De Lima, and Nogueira, who all used compounded supplements at the direction of their respective physicians or nutritionists, each accepted reduced six-month periods of ineligibility that ended upon the resolution of their cases. As such, the athletes are immediately eligible to return to competition.

Given the evidence that compounding pharmacies can pose a threat to the health and safety of Brazilian athletes, as well as the public at large, USADA will continue working with law enforcement and regulatory agencies in Brazil to investigate the operations of the offending pharmacies.

Payout Perspective:

This is another example of the issues with the UFC Anti-Doping Policy.  While there is an overarching standard that the athletes are responsible for what they ingest, this case shows that this standard may be unfair.  JDS was taken off of a fight against Francis Ngannou at UFC 215 in September 2017, giving 8-10 months of unwanted inactivity to clear his name.  It does appear that there was cooperation from all 3 fighters in order to avoid an arbitration to oppose the ruling.  Yet, the time off, more than a 6 month suspension, cannot be regained.

Filed Under: Drug Testing, Flagged by USADA, UFC, USADA

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Featured

Muhammad Ali American Boxing Revival Act of 2026 introduced into Senate with minor changes

Plaintiffs file Answering Brief in Cirkunov Antitrust Appeal

Jai Opetaia files a lawsuit against IBF

Parties in Mayweather-CSI Entertainment lawsuit provide joint letter to court

Plaintiffs highlight outstanding discovery in Johnson antitrust case

UFC 329 Payout Perspective

Archives

MMA Payout Follow

MMAPayout
Retweet on Twitter MMA Payout Retweeted

WWE merger lawsuit settlement details disclosed in 10-Q:

"WWE's portion of the overall settlement amount is $105.0 million, which is expected to be funded by probable insurance recoveries of $75M, resulting in an expected loss of $30M"

TKO beats analyst expectations with busy Q2 period

So you are saying its a 2-for-1

boosie badazz pardon approval team @scrohto

Poop has been traded for INF prospect Pee

Retweet on Twitter MMA Payout Retweeted

TKO Group Holdings released their Q2 results. UFC revenue up $120 million compared to Q2 last year. https://investor.tkogrp.com/news/news-details/2026/TKO-Reports-Second-Quarter-2026-Results/default.aspx

#Mayweather argues that CSI has not established that "alleged difficulty collecting a possible unsecured contract judgment is a legally cognizable basis for the prelim injunction it seeks."

Load More

Copyright © 2026 · MMA Payout: The Business of Combat Sports